BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  Gilead Announces U.S. FDA Priority Review Designation For Sofosbuvir/Velpatasvir For Treatment Of All Genotypes Of Chronic Hepatitis C Infection

  January 5, 2016

   · 

  2 min read
• Genetown

  Vertex Announces Upcoming Presentation At The J.P. Morgan Healthcare Conference And Date Of Fourth Quarter And Full Year 2015 Financial Results

  January 5, 2016

   · 

  1 min read
• Bio NC

  Proprietary LabCorp Clinical Decision Support Report Improves Adherence To Chronic Kidney Disease Treatment Guidelines

  January 5, 2016

   · 

  6 min read
• Pharm Country

  Amneal To Present At 34th Annual J.P. Morgan Healthcare Conference

  January 5, 2016

   · 

  1 min read
• Drug Development

  Akebia Initiates Phase 3 PRO2TECT Program

  January 5, 2016

   · 

  8 min read
• Pharm Country

  Pfizer Invites Public To Listen To Webcast Of Pfizer And Allergan Discussion At 34th Annual J.P. Morgan Healthcare Conference

  January 5, 2016

   · 

  1 min read
• BioForest

  Biotechnology Industry Organization Changes Name To Biotechnology Innovation Organization

  January 5, 2016

   · 

  1 min read
• Pharm Country

  Bristol-Myers Squibb To Present At J.P. Morgan Healthcare Conference

  January 5, 2016

   · 

  1 min read
• ICON Secures Investment Grade Credit Ratings

  January 5, 2016

   · 

  1 min read
• Genetown

  Acceleron Pharma Announces Proposed Public Offering Of Common Stock

  January 5, 2016

   · 

  1 min read